Article info

Download PDFPDF

511 T cell-instructed inflammation drives immune checkpoint inhibitor therapy resistance
Free

Authors

  • Nam Woo Cho Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Sophia Guldberg Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Eun Ji Kim Unaffiliated, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Kamir Hiam-Galvez Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Katherine Wai Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Lauren Levine Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Rachel DeBarge Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Jacqueline Yee Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Naa Ashitey Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Matthew Spitzer Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles

Citation

Cho NW, Guldberg S, Kim EJ, et al
511 T cell-instructed inflammation drives immune checkpoint inhibitor therapy resistance

Publication history

  • First published November 7, 2022.
Online issue publication 
November 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.